UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of February 2025
Commission File Number: 001-40614
INTERCURE LTD.
(Translation of registrant’s name into English)
85 Medinat ha-Yehudim Street
Herzliya, 4676670, Israel
Tel: +972 77 460 5012
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
| Form 20-F ☒ | Form 40-F ☐ |
On February 3, 2025, an Extraordinary General Meeting of Shareholders of Intercure Ltd. (the “Company” and the “Meeting,” respectively) approved the proposal brought before the Company’s shareholders at the Meeting, in accordance with the majority required for such proposal. This proposal was described in the Company’s Notice and Proxy Statement with respect to the Meeting dated December 20, 2024, attached as Exhibit 99.1 to the Company’s Form 6-K dated December 20, 2024, as subsequently amended as reflected in Exhibit 99.1 to the Company’s Form 6-K/A dated January 31, 2025.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| INTERCURE LTD. | |
| Date: February 3, 2025 | /s/ Amos Cohen |
| Amos Cohen | |
| Chief Financial Officer |